<DOC>
	<DOCNO>NCT01468441</DOCNO>
	<brief_summary>The present prospective study design compare effect administer daily dose gonadotrophin release hormone ( GnRH ) antagonist vs. alternate-day dosage GnRH agonist ovarian response vitro fertilization ( IVF ) outcome patient stimulate recombinant follicle-stimulating hormone ( FSH ) human chorionic gonadotrophin ( hCG ) microdose .</brief_summary>
	<brief_title>Ovarian Stimulation Using Recombinant Follicle-stimulating Hormone ( FSH ) Gonadotrophin Releasing Hormone ( GnRH ) Agonist Alternate Days</brief_title>
	<detailed_description>Inclusion criterion follow : woman good physical mental health , 37 year old , regular menstrual cycle 25-35 day , normal basal FSH luteinizing hormone ( LH ) level , body mass index ( BMI ) less 30 kg/m2 , presence ovary intact uterus , absence polycystic ovary , endometriosis , gynaecological / medical disorder negative result screen sexually transmit disease . No patient receive hormone therapy least 60 day precede study . Eligible patient agree participate randomize two treatment group . Patients allocate GnRH analogue treatment group accord computer-generated randomization table .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Triptorelin Pamoate</mesh_term>
	<mesh_term>Cetrorelix</mesh_term>
	<mesh_term>Deslorelin</mesh_term>
	<mesh_term>Follicle Stimulating Hormone</mesh_term>
	<criteria>woman good physical mental health 37 year old , regular menstrual cycle 2535 day normal basal FSH LH level BMI le 30 kg/m2 presence ovary intact uterus absence polycystic ovary endometriosis , gynaecological / medical disorder negative result screen sexually transmit diseases patient sign write informed consent form patient receive hormone therapy least 60 day precede study .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>ovarian stimulation</keyword>
	<keyword>GnRH agonist</keyword>
	<keyword>GnRH antagonist</keyword>
	<keyword>hCG microdose</keyword>
	<keyword>ICSI</keyword>
</DOC>